NCT03284515|CompletedDMC
Loading search results
Sponsor study identifier
observational
30
1 country
1
Study Start
September 7, 2017
Actual (reported)Primary Completion
January 31, 2018
Actual (reported)Study Completion
March 21, 2018
Actual (reported)A study investigating gene expression profiles in pregnant women in response to a pertussis containing vaccination in pregnancy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 21, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 7, 2017
Actual (reported)September 13, 2017
Actual (reported)September 15, 2017
Actual (reported)January 31, 2018
Actual (reported)March 21, 2018
Actual (reported)Gene expression profiles
Gene expression profiles in blood samples from pregnant women following vaccination.
24 hours
Women who are between 16-32 weeks gestation and who have not previously received a pertussis vaccination in pregnancy.
Vaccination with a pertussis containing vaccine
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pregnant women at between 16-32 weeks gestation who have not yet received the pertussis vaccination in pregnancy.
St George's, University of London
London, SW170RE, United Kingdom
Blood samples will be taken from the women prior to and 24 hours following vaccination.
30 participants (actual enrollment reported by the registry).
First Submitted
September 13, 2017
First Posted
September 15, 2017
Study Start
September 7, 2017
Actual (reported)Home Pregnancy Test Evaluation, Lay User Study
Contact the study team to confirm eligibility.
Primary Completion
January 31, 2018
Actual (reported)Study Completion
March 21, 2018
Actual (reported)Last Updated
January 11, 2021
Record last verified: 2021-01
Personal details of the participants will be collected to allow us to contact them if necessary. This information will be stored securely and will not leave St. George's, University of London. Some limited demographic and medical information may be shared with researchers at Imperial College London and the Max Planck Institute for Infection Biology both of which are part of this study and the wider BioVacSafe consortium.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: